Menu
GWAS Study

Congenital heart disease risk loci identified by genome-wide association study in European patients.

Lahm H, Jia M, Dreßen M et al.

33201861 PubMed ID
GWAS Study Type
12520 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LH
Lahm H
JM
Jia M
DM
Dreßen M
WF
Wirth F
PN
Puluca N
GR
Gilsbach R
KB
Keavney BD
CJ
Cleuziou J
BN
Beck N
BO
Bondareva O
DE
Dzilic E
BM
Burri M
KK
König KC
ZJ
Ziegelmüller JA
AC
Abou-Ajram C
NI
Neb I
ZZ
Zhang Z
DS
Doppler SA
ME
Mastantuono E
LP
Lichtner P
EG
Eckstein G
HJ
Hörer J
EP
Ewert P
PJ
Priest JR
HL
Hein L
LR
Lange R
MT
Meitinger T
CH
Cordell HJ
MB
Müller-Myhsok B
KM
Krane M
Chapter II

Abstract

Summary of the research findings

Genetic factors undoubtedly affect the development of congenital heart disease (CHD) but still remain ill defined. We sought to identify genetic risk factors associated with CHD and to accomplish a functional analysis of SNP-carrying genes. We performed a genome-wide association study (GWAS) of 4034 White patients with CHD and 8486 healthy controls. One SNP on chromosome 5q22.2 reached genome-wide significance across all CHD phenotypes and was also indicative for septal defects. One region on chromosome 20p12.1 pointing to the MACROD2 locus identified 4 highly significant SNPs in patients with transposition of the great arteries (TGA). Three highly significant risk variants on chromosome 17q21.32 within the GOSR2 locus were detected in patients with anomalies of thoracic arteries and veins (ATAV). Genetic variants associated with ATAV are suggested to influence the expression of WNT3, and the variant rs870142 related to septal defects is proposed to influence the expression of MSX1. We analyzed the expression of all 4 genes during cardiac differentiation of human and murine induced pluripotent stem cells in vitro and by single-cell RNA-Seq analyses of developing murine and human hearts. Our data show that MACROD2, GOSR2, WNT3, and MSX1 play an essential functional role in heart development at the embryonic and newborn stages.

4,034 European ancestry cases, 8,486 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

12520
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Germany, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.